Probiotics and Diverticular Disease: Evidence-based?

Area of Science:

• Gastroenterology
• Microbiology
• Nutritional Science

Background:

• Diverticular disease (DD) is a prevalent gastrointestinal condition with a spectrum from asymptomatic to complicated forms.
• Uncomplicated DD symptoms can overlap with irritable bowel syndrome, involving low-grade inflammation, altered gut microbiota, and motility issues.
• Probiotics show promise for DD due to anti-inflammatory effects and microbial balance modulation.

Purpose of the Study:

• To review the current evidence on the efficacy of prebiotics in managing uncomplicated diverticular disease (DD).

Main Methods:

• Systematic review of existing scientific literature.
• Analysis of studies investigating prebiotic interventions in patients with uncomplicated DD.
• Evaluation of clinical outcomes and biomarker changes.

Main Results:

• Prebiotics may positively influence gut microbiota composition in DD patients.
• Emerging evidence suggests potential benefits of prebiotics in alleviating uncomplicated DD symptoms.
• Further research is needed to establish optimal prebiotic strategies for DD management.

Conclusions:

• Prebiotics represent a promising therapeutic avenue for uncomplicated diverticular disease.
• Modulating the gut microbiota with prebiotics could be a key strategy for symptom management.
• High-quality clinical trials are necessary to confirm the efficacy and safety of prebiotics in DD.